UV Dosimetry Feedback in NMSC Patients

Status Withdrawn

Clinical Trial Summary

This study aims to characterize UV exposures among NMSC patients (those with a history of skin cancer) and to pilot an innovative behavioral intervention to decrease modifiable UV exposures. It will use UV dosimeters to objectively measure UV exposure and provide time and activity specific UV data on an individual level. These data will be used to develop a targeted and personalized behavioral feedback plan with counseling aimed at effective sun exposure behavior change

Clinical Trial Description

The study will focus on helping to prevent NMSC and its associated morbidity through learning when patients are unintentionally exposed to extreme UV radiation. It will then help to create manageable and realistic behavioral interventions to reduce exposure, while also educating patients of the dangers of abundant sun exposure. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03757663
Study type	Interventional
Source	University of Colorado, Denver
Contact
Status	Withdrawn
Phase	N/A
Start date	March 12, 2018
Completion date	August 30, 2019

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04103658` - NIR and Skin Cancer Margins	N/A
Completed	`NCT01053819` - Can We Miss Pigmented Lesions in Psoriasis Patients?	Phase 4
Recruiting	`NCT03767348` - Study of RP1 Monotherapy and RP1 in Combination With Nivolumab	Phase 2
Recruiting	`NCT05429866` - Immunological Variables Associated to ICI Toxicity in Cancer Patients	Phase 2
Active, not recruiting	`NCT02636569` - Topical Chemoprevention of Skin Cancer Biomarkers	Phase 2
Completed	`NCT02780934` - Comparing Pressure Versus Simple Adhesive Dressing After Mohs Reconstruction	N/A
Completed	`NCT02760160` - Dietary Prevention of Photodamage in Skin With Grapes	N/A
Completed	`NCT02872909` - Randomized Comparison of Low and Conventional Irradiance PDT for Skin Cancer	N/A
Withdrawn	`NCT03327064` - A Biomarker Evaluation Trial of UAB30 in Renal Transplant Recipients at High Risk for Non-melanoma Skin Cancer	Phase 1/Phase 2
Completed	`NCT00342407` - The Incidence of Breast and Other Cancers Among Female Flight Attendants
Terminated	`NCT04410874` - Imvamune Vaccine for the Treatment of Non-melanoma Skin Cancer	Phase 1/Phase 2
Completed	`NCT03693937` - A Retrospective Evaluation of Superficial Radiation Therapy (SRT) and Non-Melanoma Skin Cancer (NMSC)
Completed	`NCT04334824` - Hydrochlorothiazide and Risk of Skin Cancer
Recruiting	`NCT05878288` - Deep sequencIng in Cutaneous Squamous CEll caRciNomas	Phase 2
Completed	`NCT01359735` - Healing Effects of HP802-247 Versus Antibiotic Ointment in Mohs Micrographic Surgery Patients	Phase 2
Terminated	`NCT04348916` - Study of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid Tumors	Phase 1
Enrolling by invitation	`NCT05257486` - Post-market Multi-Center RETRO-Prospective Study to Assess Long-term Clinical Outcomes NMSC Patients Treated With eBx
Completed	`NCT04116983` - DERM NMSC Validation Study
Active, not recruiting	`NCT06227416` - Skin Tumor Biomarkers by Mass Spectrometry Imaging	N/A
Recruiting	`NCT05932511` - Topical Ascorbic Acid for Treatment of Squamous Cell Skin Cancer	Early Phase 1